Literature DB >> 3820354

In vivo monitoring of postburn immune response.

J Shelby, S W Merrell.   

Abstract

Following a severe thermal injury (30% TBSA), 50% of the burned mice died within 48 hours. The immune response of the survivors was evaluated in vivo using the popliteal lymph node assay (PLNA) for host versus graft (HVG) or graft versus host (GVH) response. Suppression of GVH reactivity was observed using isolated splenocytes from burned mice harvested on postburn days 3, 8, and 11. Lymphocyte response evaluated in the burn environment using the HVG assay was profoundly deficient on postburn days 3 and 11. Recovery of immune function as determined by measurements of both responses occurred by postburn days 14-21, and coincided with wound healing. The PLNA proved to be a sensitive measure of immune function, and allowed for the evaluation of isolated cell populations, as well as measurement of lymphocyte function in the burn environment in the presence of circulating suppressor factors.

Entities:  

Mesh:

Year:  1987        PMID: 3820354     DOI: 10.1097/00005373-198702000-00021

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  4 in total

Review 1.  Nanofibers offer alternative ways to the treatment of skin infections.

Authors:  T D J Heunis; L M T Dicks
Journal:  J Biomed Biotechnol       Date:  2010-07-28

2.  Pathogen distribution and drug resistance in a burn ward: a three-year retrospective analysis of a single center in China.

Authors:  Hanghui Cen; Zhenbo Wu; Fan Wang; Chunmao Han
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  The Use of Procalcitonin (PCT) for Diagnosis of Sepsis in Burn Patients: A Meta-Analysis.

Authors:  Luís Cabral; Vera Afreixo; Luís Almeida; José Artur Paiva
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

4.  Antimicrobial resistance and pathogen distribution in hospitalized burn patients: A multicenter study in Southeast China.

Authors:  Lin Li; Jia-Xi Dai; Le Xu; Zhao-Hong Chen; Xiao-Yi Li; Min Liu; Yu-Qing Wen; Xiao-Dong Chen
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.